Deucravacitinib, a selective, allosteric tyrosine kinase 2 inhibitor, in scalp psoriasis: a subset analysis of two phase 3 randomized trials in plaque psoriasis
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
Plain Language Summary for Original Article titled "Deucravacitinib, a selective, allosteric tyrosine kinase 2 inhibitor, in scalp psoriasis: a subset analysis of two phase 3 randomized trials in plaque psoriasis".
创建时间：
2023-12-12
